Could a bag CPAP device save lives in Low-Resource hospitals?

NCT ID NCT07460427

Not yet recruiting Disease control Sponsor: Prof RWABIHAMA Jean Paul Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a Bag CPAP device, added to standard oxygen, can reduce the need for breathing tubes in adults with acute hypoxemic respiratory failure. Researchers in Rwanda will randomly assign 250 patients to receive either Bag CPAP plus oxygen or oxygen alone. The main goal is to see if fewer patients meet criteria for intubation by day 7.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Bag CPAP device
What this could lead to: If it works, this could provide a low-cost way to reduce the need for breathing tubes and improve survival in resource-limited hospitals.
What could go wrong: This is an early-stage trial in one country, and the device may cause side effects like skin sores or sinusitis. It may not reduce intubation rates as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HYPOXEMIC RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE HYPOXEMIC RESPIRATORY FAILURE

Contacts and locations

Locations

University of Rwanda

Kigali, Rwanda

More trials for these conditions

Other studies related to the condition(s) this trial covers.